Demo Viewer

Strategy

OVYN Brain Trust

The people standing behind the platform.

Pharma DTC isn't a market AI generalists win. It's a market won by people who understand how a board reviews creative, how MLR scores risk, and what an OPDP letter can do to a launch quarter. The OVYN Brain Trust is where that weight comes from.

Active anchors

Maha Elashri

Founding Partner · Pharma DTC + Clinical Voice

OVYN · Wellness Bureau

20+ years across pharma DTC, agency, and clinical operations. Cardiology RN by training. Built the brand-strategy practices behind multiple top-25 biotech launches. Anchors OVYN's pharma side and runs every client engagement personally for the first 90 days.

LinkedIn →

Kirten Parekh, MD

Medical Direction · Cardiology + Longevity

Eternal Longevity

Board-certified physician, NJ MD-78421, PA MD-12104. Eight years in private practice across two clinics. Anchors the clinical-fluency side of Intelligence — every cardiology / metabolic / longevity rule set is reviewed against his practice protocols.

Eternal Longevity →

Slots open · in conversation

Regulatory Voice · ex-FDA OPDP

in conversation

A former OPDP reviewer or top-tier MLR consultant. Adds regulatory gravity to Content Engine rule design.

Pharma DTC Operator · ex-CMO biotech

in conversation

A retired or consulting CMO from a top-25 biotech. Adds buyer-side credibility and helps tune the engagement model.

AI Governance · regulated industries

target

An AI-and-policy researcher from healthcare, financial services, or government. Anchors the trust posture beyond pharma-only audiences.

Clinical KOL · rare disease / oncology

target

A KOL-adjacent voice in a high-value indication. Front-runs Intelligence depth in the verticals our clients buy first.

How this wall is run

Three principles

Principle 01

Named or not at all.

Every advisor on this page is real, named, and reachable. We don't list orgs our advisors used to work at as if they were customers. We don't list customers we don't have. The wall is a credibility instrument; instruments only work when they're true.

Principle 02

Clinical and regulatory weight, not just AI hype.

Pharma's advisor walls work because pharma respects pharma. Our weight comes from a board-certified MD, a 20-year DTC operator, and (next) a regulatory voice — not from the latest LLM-research celebrity. Clinical fluency outpunches AI vocabulary in this market.

Principle 03

Compensation is disclosed.

Advisors receive quarterly retainers and modest equity. We disclose the structure on request. Nobody on this page is paid to say things they don't believe; nobody is here as a favor that runs out.

Building the wall

If this is your seat — we should talk.

We're actively conversing with regulatory and pharma-operator advisors. Quarterly retainer + advisor equity, structured terms, no bait. Email advisor@ephicacyhealth.com with a one-line note about your background.

Or start a pilot →

Forward thisOne click to the right page for whoever you need to loop in.

Exec one-pager → CMO Trust & Compliance → Security Engagement → Procurement Track record → Skeptic FAQ → Anyone Start a pilot → Action

What's underneathArchitecture · advisors · published thinking.

Architecture Intelligence · Content Engine · Activation · Measurement Brain Trust Named advisors Research Ephicacy Health · published

Talk to us30 minutes with Maha + Zein. No deck, no sales motion. We answer your questions.

Schedule a demo →hello@ephicacyhealth.com